Tirz GLP-1 (Dry) 30mg

Tirz GLP-1 (Dry Powder Formulation) Dual-Incretin Therapy in a Compounded, Convenient Format

Tirz GLP-1, now available in a compounded dry powder formulation, offers physicians a flexible and clinically advanced option for medical weight loss and metabolic support. As a dual GLP-1 and GIP receptor agonist, Tirz GLP-1 targets two key incretin pathways, resulting in superior appetite control, glycemic regulation, and fat loss compared to GLP-1 monotherapy.

This preservative-free dry powder format is ideal for practices seeking customized dosing and longer shelf stability, while maintaining clinical efficacy.

Why Choose Tirz GLP-1 in Dry Powder Form?

• Dual-action mechanism: Activates both GLP-1 and GIP receptors to optimize metabolic response and weight loss
• Compounded for flexibility: Enables personalized titration based on patient needs and response
• Convenient storage & reconstitution: Extended shelf life and easy-to-use reconstitution protocols for in-office or at-home use
• Clean formulation: Free from preservatives for patients with sensitivities or simpler protocols

Clinical Benefits:

• Enhanced weight loss and appetite suppression
• Slowed gastric emptying and reduced caloric intake
• Improved insulin sensitivity and glycemic control
• Custom dosing options to reduce GI-related side effects and optimize adherence
• Suitable for a range of metabolic health programs

Formulation: Dry powder for reconstitution; weekly subcutaneous injection

Availability: Patient-specific prescriptions through licensed compounding pharmacies

Offer your patients a next-generation, dual-pathway treatment in a convenient, customizable dry powder format—built for modern metabolic care.